Platelet-activating factor stimulates ovine foetal pulmonary vascular smooth muscle cell proliferation: Role of nuclear factor-kappa B and cyclin-dependent kinases

Cell Proliferation

Volumn 41, Issue 2, 2008, Pages 208-229

  Ibe, B O ^a   Abdallah, M F ^a   Portugal, A M ^a   Raj, J U ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; THYMIDINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EWE; FEMALE; FETUS; HYPOXIA; LUNG ALVEOLUS CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULMONARY VEIN; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANOXIA; AZEPINES; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; OXYGEN; PLATELET ACTIVATING FACTOR; PULMONARY ARTERY; PULMONARY VEINS; SHEEP; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

BOVINAE; OVIS;

EID: 40649095739     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2008.00517.x     Document Type: Article

References (47)

1. Ali H, Richardson RM, Tomhave ED, Dubose RA, Haribabu B, Snyderman R (1994) Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. J. Biol. Chem. 269, 24557 24563.
2. Amrani Y, Tliba O, Choubey D, Huang C-D, Krymskaya VP, Eszterhas A, Lazaar AL, Panettieri RA Jr. (2003) IFN-inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 84, L1063 L1071.
3. Berk BC (2001) Vascular smooth muscle cell growth: autocrine growth mechanisms. Physiol. Rev. 81, 999 1032.
4. Berthet C, Kaldis P (2006) Cdk2 and Cdk4 cooperatively control the expression of cdc2. Cell Div. 1, 1 6.
5. Berthet C, Klarmann KD, Hilton MB, Suh HC, Keller JR, Kiyokawa H, Kaldis P (2006) Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation. Dev. Cell 10, 563 573.
6. Brunet A, Roux D, Lenomand P, Dowd S, Keyse S, Pouyssegur J (1999) Nuclear translocation of p42/44 mitogen-activated protein kinases required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18, 644 674.
7. Bussolino F, Camussi G (1995) Platelet activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur. J. Biochem. 229, 327 337.
8. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nature Med. 6, 389 395.
9. Chabrier PE (1996) Growth factors and vascular wall. Int. Angiol. 15, 100 103.
10. Dutta J, Fan Y, Gupta N, Fan G, Gélinas C (2006) Current insights into the regulation of programmed cell death by NF-κB. Oncogene 25, 6800 6816.
11. Fineman JR, Soifer SJ, Heymann MA (1995) Regulation of pulmonary vascular tone in the perinatal period. Annu. Rev. Physiol. 57, 115 134.
12. Fischer A, Müller D, Zimmermann-Kordmann M, Kleuser B, Mickeleit M, Laabs S, Werner Löwe W, Cantagrel F, Reutter W, Danker K (2006) The ether lipid inositol-C2-PAF is a potent inhibitor of cell proliferation in HaCaT cells. Chembiochem 7, 441 449.
13. 1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am. J. Physiol. Cell Physiol. 287, C281 C291.
14. Gaumond F, Fortin D, Stankova J, Rola-Pleszczynski M (1997) Differential signaling pathways in platelet-activating factor-induced proliferation and interleukin production by rat vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 30, 169 175.
15. Hassoun P, Thappa V, Landman M, Fanburg B (1992) Endothelin 1: mitogenic acivity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc. Exp. Biol. Med. 199, 165 170.
16. Haworth S, Reid L (1976) Persitent fetal circulation: newly recognized structural features. J. Pediatr. 88, 614 620.
17. Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, Prescott SM (1995) Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J. Clin. Invest. 96, 2322 2330.
18. Ibe BO, Hibler S, Raj JU (1998) Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb. J. Appl. Physiol. 85, 1079 1085.
19. Ibe BO, Sander FC, Raj JU (2000) Platelet-activating factor receptors in lamb lungs are down-regulated immediately after birth. Am. J. Physiol. Heart Circ. Physiol. 278, H1168 H1176.
20. Ibe BO, Portugal AM, Chaturvedi S, Raj JU (2005) Oxygen-dependent PAF receptor binding and intracellular signaling in ovine fatal pulmonary vascular smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L879 L886.
21. Ibe BO, Portugal AM, Raj JU (2006) Levalbuterol inhibits human airway smooth muscle cell proliferation: therapeutic implications in the management of asthma. Int. Arch. Allergy Immunol. 139, 225 236.
22. Ibe BO, Ameer A, Portugal AM, Renteria L, Raj JU (2007) Platelet-activating factor modulates activity of cyclic nucleotides in fetal ovine pulmonary vascular smooth muscle. J. Pharmacol. Exp. Ther. 320, 728 737.
23. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P (2001) Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl. Acad. Sci. USA 98, 4202 4208.
24. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev. 12, 149 162.
25. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an RB mutation in the mouse. Nature 359, 295 300.
26. Lopez-Ilasaca M, Crespo P, Pallici PG, Gutkind JS, Wetzker R (1997) Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3 kinase gamma. Science 275, 394 397.
27. Malumbres M, Ortega S, Barbacid M (2000) Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors. Biol. Chem. 381, 827 838.
28. McManus LM, Pinckard RN (2000) PAF, a putative mediator of oral inflammation. Crit. Rev. Oral Biol. Med. 11, 240 258.
29. Nagy I, Caelers A, Monge A, Bonabi S, Huber AM, Bodmer D (2007) NF-kappa B-dependent apoptotic hair cell death in the auditory system. Audiol. Neorootol. 12, 209 220.
30. Ninio E (2006) Phospholip mediators in the vessel wall: involvement in atherosclerosis. Curr. Opin. Clin. Nutr. Metab. Care 8, 123 131.
31. Palmer RM, Rees DD, Ashton DS, Moncada S (1988) L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153, 1251 1256.
32. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153 183.
33. Perkins ND (2006) Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25, 6717 6713.
34. Prendes M, Zheng Y, Beg AA (2003) Regulation of developing B cell survival by RelA-containing NF-κB complexes. J. Immunol. 171, 3963 3969.
35. Raisanen A, Mennander A, Ustinov J, Paavonen T (1993) Effect of platelet-activating factor (PAF) receptor blockers on smooth muscle cell replication in vitro and allograft arteriosclerosis in vivo. Transpl. Int. 6, 251 257.
36. Rose DM, Fadok VA, Riches DWH, Clay KL, Henson PM (1995) Autocrine/paracrine involvement of platelet-activating factor and transforming growth factor-β in the induction of phosphatidylserine recognition by murine macrophages. J. Immunol. 155, 5819 5825.
37. Schultz K, Fanburg BL, Beasley D (2006) Hypoxia and hypoxia-inducible factor-1α promote growth factor-induced proliferation of human vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 290, H2528 H2534.
38. Schwartz SM, Heinmark RL, Majesky MW (1990) Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70, 1177 1209.
39. Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM (2003) Platelet activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit. Rev. Clin. Lab. Sci. 40, 643 672.
40. Suh S-J, Jin U-H, Kim S-H, Chang H-W, Son J-K, Lee SH, Son K-H, Kim C-H (2006) Ochnaflavone inhibits TNF-α-induced human VSMC proliferation via regulation of cell cycle, ERK1/2, and MMP-9. J. Cell. Biochem. 99, 1298 1307.
41. Toga H, Hibler S, Ibe BO, Raj JU (1992) Vascular effects of platelet-activating factor in lambs: role of cyclo- and lipoxygenase. J. Appl. Physiol. 73, 2559 2566.
42. Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, Haegeman G (1998) p38 extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273, 3285 3290.
43. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G (2003) Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 22, 1313 1324.
44. Wang H, Tan X-d, Chang H, Gonzales-Crussi F, Remik DG, Hsueh W (1997) Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumor necrosis factor. Biochem. J. 322, 603 608.
45. A receptor-mediated generation of hydrogen peroxide. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L480 L487.
46. Yu AY, Shimoda LA, Iyer NV, Huso DL, sun X, McWilliams R, Beaty T, Sham JSK, Wiener CM, Sylvester JT, Semanza GL (1999) Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J. Clin. Invest. 103, 691 696.
47. Zhou W, Ibe BO, Raj JU (2007) Platelet activating factor induces ovine fetal pulmonary venous smooth muscle cell proliferation: role of epidermal growth factor receptor transactivation. Am. J. Physiol. Heart Circ. Physiol. 292, H2773 H2781.